Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas-Reference-Cited by-同舟云学术

Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas

Published:2005-03-01 Issue:5 Volume:11 Page:1776-1785
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Fukumoto Shin-ichi,Yamauchi Naoko,Moriguchi Hisashi,Hippo Yoshitaka,Watanabe Akira,Shibahara Junji,Taniguchi Hirokazu,Ishikawa Shumpei,Ito Hirotaka,Yamamoto Shogo,Iwanari Hiroko,Hironaka Mitsugu,Ishikawa Yuichi,Niki Toshiro,Sohara Yasunori,Kodama Tatsuhiko,Nishimura Masaharu,Fukayama Masashi,Dosaka-Akita Hirotoshi,Aburatani Hiroyuki

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids;Clinical Cancer Research;2024-07-17

2. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment;Scientific Reports;2024-05-27

3. Role of AKR1B10 in inflammatory diseases;Scandinavian Journal of Immunology;2024-05-20

4. AKR1B10 Expression Characteristics in Hepatocellular Carcinoma and Its Correlation with Clinicopathological Features and Immune Microenvironment;2024-01-23

5. Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss;Free Radical Biology and Medicine;2024-01